Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quanterix (QTRX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Quanterix (QTRX) over the last 10 years, with Q3 2025 value amounting to $38.3 million.

  • Quanterix's Cash & Equivalents rose 3053.61% to $38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.3 million, marking a year-over-year increase of 3053.61%. This contributed to the annual value of $56.7 million for FY2024, which is 6748.75% down from last year.
  • According to the latest figures from Q3 2025, Quanterix's Cash & Equivalents is $38.3 million, which was up 3053.61% from $132.9 million recorded in Q2 2025.
  • Quanterix's Cash & Equivalents' 5-year high stood at $442.7 million during Q1 2021, with a 5-year trough of $29.3 million in Q3 2024.
  • In the last 5 years, Quanterix's Cash & Equivalents had a median value of $329.4 million in 2023 and averaged $240.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 38507.98% in 2021, then tumbled by 8625.16% in 2024.
  • Quarter analysis of 5 years shows Quanterix's Cash & Equivalents stood at $396.5 million in 2021, then dropped by 14.57% to $338.7 million in 2022, then crashed by 48.51% to $174.4 million in 2023, then crashed by 67.49% to $56.7 million in 2024, then plummeted by 32.47% to $38.3 million in 2025.
  • Its Cash & Equivalents was $38.3 million in Q3 2025, compared to $132.9 million in Q2 2025 and $76.5 million in Q1 2025.